MAL Stats & Data

- Identity and nomenclature: MAL is 3,5-dimethoxy-4-methallyloxyphenethylamine; the methallyl (2‑methylallyl) ether at the 4-position makes it an escaline-family analogue. This specific naming helps distinguish it from mescaline analogues with 3,4,5-trimethoxy patterns. (Source: PiHKAL·info entry and IUPAC listing).

- Very slow, sometimes deceptive onset (60–120 min) is frequently reported; premature redosing is a common cause of excessive body-load and adverse effects—avoid any redose before 3 hours and consider split-dosing only after prior experience. (Anecdotal consensus across BL/Erowid).

- Long duration (10–16 h) plus residual after-effects can impact sleep and next-day function; don’t drive, cycle, swim, or operate machinery during and after. Plan an unhurried, temperature‑controlled setting with trusted support.

- Nausea and GI cramping are common in the first hours; bland pre-meal, ginger/peppermint, and avoiding heavy fats can help. Some find sublingual/insufflation reduces nausea but increases stimulation and local irritation. (Anecdotal).

- Peripheral stimulation/vasoconstriction and mild hypertension can occur; combining with stimulants (including high-dose caffeine) increases cardiovascular strain—avoid such mixes, especially if you have cardiovascular risk factors. (General HR + TripSit chart rationale).

- Urinary retention has been repeatedly reported anecdotally with moderate–high doses; inability to void for many hours is a red flag. Avoid anticholinergics (e.g., diphenhydramine), stay hydrated with electrolytes, and seek urgent care if painful retention persists (>6–8 h), if there’s flank pain, or if you feel systemically unwell. Do not self‑medicate with prescription alpha‑blockers without medical supervision. (Anecdotal; community warnings).

- Salt forms: “MAL fumarate” has appeared in drug checking contexts and can be laid on blotter. Salt form changes mg‑for‑mg potency by mass; if unknown, titrate from the low end and do an allergy test with each new batch.

- Reagent/drug checking: MAL has been found on blotter, a format often used for long‑acting phenethylamines; always test. Reagents may not be definitive; GC/MS (e.g., DrugsData) or a local service provides confirmation.

- Allergy test: For any new batch, especially RCs, start with 1–2 mg to screen idiosyncratic reactions, then stepwise titrate on a different day.

- Mental set: As with other psychedelics, strong alterations in thought and perception occur; having a sober sitter, a plan for anxiety management (breathing, environment control), and avoiding emotionally charged settings reduces risk.

- Medical cautions: People with BPH/prostate issues, urinary tract problems, uncontrolled hypertension, or significant cardiovascular disease should avoid MAL without medical clearance due to retention and BP risks.

- Do not mix with lithium (seizure/coma risk reported with psychedelics) or MAOIs (unpredictable potentiation and hypertension risk). Tramadol is risky due to serotonergic and seizure‑threshold effects.

- Hydration: Sip fluids regularly; add electrolytes if sweating or active. Overhydration can be harmful—avoid chugging large volumes rapidly.

- Sleep protection: Expect sleep disruption; prepare a dark, quiet space and non-pharmacologic sleep hygiene rather than sedative stacking post‑trip.